Literature DB >> 8735615

The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH-SY5Y human neuroblastoma cell line.

M Connor1, A Yeo, G Henderson.   

Abstract

The human neuroblastoma cell line SH-SY5Y expresses the 'orphan' opioid receptor (ORL1). We have demonstrated that nociceptin, the putative endogenous ligand for ORL1, produces a concentration-dependent inhibition of the N-type calcium channel current in these cells (IC50 42 nM). In addition, in the presence of carbachol, nociceptin increased the intracellular concentration of Ca2+ (EC50 60 nM). Both effects of nociceptin were blocked by pertussis toxin pretreatment but not by the opioid antagonists CTAP (1 microM), naltrindole (1 microM) and naloxone (10 microM).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735615      PMCID: PMC1909632          DOI: 10.1111/j.1476-5381.1996.tb15387.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

1.  Mu-opioid-receptor-mediated inhibition of the N-type calcium-channel current.

Authors:  E Seward; C Hammond; G Henderson
Journal:  Proc Biol Sci       Date:  1991-05-22       Impact factor: 5.349

2.  Chronic exposure to morphine does not induce dependence at the level of the calcium channel current in human SH-SY5Y cells.

Authors:  C Kennedy; G Henderson
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

3.  Demonstration of kappa 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line.

Authors:  J Cheng; K M Standifer; P R Tublin; W Su; G W Pasternak
Journal:  J Neurochem       Date:  1995-07       Impact factor: 5.372

4.  ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.

Authors:  C Mollereau; M Parmentier; P Mailleux; J L Butour; C Moisand; P Chalon; D Caput; G Vassart; J C Meunier
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

5.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor.

Authors:  J C Meunier; C Mollereau; L Toll; C Suaudeau; C Moisand; P Alvinerie; J L Butour; J C Guillemot; P Ferrara; B Monsarrat
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

6.  Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor.

Authors:  R K Reinscheid; H P Nothacker; A Bourson; A Ardati; R A Henningsen; J R Bunzow; D K Grandy; H Langen; F J Monsma; O Civelli
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

  6 in total
  43 in total

1.  Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism.

Authors:  Louise M Collins; Giorgia Dal Bo; Mariangela Calcagno; Jimena Monzón-Sandoval; Aideen M Sullivan; Humberto Gutierrez; Michele Morari; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2015-12-21       Impact factor: 5.590

2.  Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices.

Authors:  B Nicol; D G Lambert; D J Rowbotham; D Smart; A T McKnight
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Nociceptin inhibits T-type Ca2+ channel current in rat sensory neurons by a G-protein-independent mechanism.

Authors:  F A Abdulla; P A Smith
Journal:  J Neurosci       Date:  1997-11-15       Impact factor: 6.167

4.  Effects of nociceptin and nocistatin on antidromic vasodilatation in hairless skin of the rat hindlimb in vivo.

Authors:  H Häbler; L Timmermann; J Stegmann; W Jänig
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

5.  Axotomy reduces the effect of analgesic opioids yet increases the effect of nociceptin on dorsal root ganglion neurons.

Authors:  F A Abdulla; P A Smith
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

6.  Buprenorphine: a unique drug with complex pharmacology.

Authors:  Kabirullah Lutfy; Alan Cowan
Journal:  Curr Neuropharmacol       Date:  2004-10       Impact factor: 7.363

Review 7.  The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability.

Authors:  Ann P Lin; Mei-Chuan Ko
Journal:  ACS Chem Neurosci       Date:  2012-11-06       Impact factor: 4.418

Review 8.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

9.  Kainic acid down-regulates NOP receptor density and gene expression in human neuroblastoma SH-SY5Y cells.

Authors:  Rosalia Cannarsa; Daniela Landuzzi; Chiara Cavina; Sanzio Candeletti; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2008-02-20       Impact factor: 3.444

10.  The role of NOP receptors in psychomotor stimulation and locomotor sensitization induced by cocaine and amphetamine in mice.

Authors:  Paul Marquez; Abdul Hamid; Kabirullah Lutfy
Journal:  Eur J Pharmacol       Date:  2013-03-21       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.